Molecules (May 2024)

Advances in Nucleic Acid Assays for Infectious Disease: The Role of Microfluidic Technology

  • Yiran Wang,
  • Jingwei Chen,
  • Zhijin Yang,
  • Xuanyu Wang,
  • Yule Zhang,
  • Mengya Chen,
  • Zizhen Ming,
  • Kaihuan Zhang,
  • Dawei Zhang,
  • Lulu Zheng

DOI
https://doi.org/10.3390/molecules29112417
Journal volume & issue
Vol. 29, no. 11
p. 2417

Abstract

Read online

Within the fields of infectious disease diagnostics, microfluidic-based integrated technology systems have become a vital technology in enhancing the rapidity, accuracy, and portability of pathogen detection. These systems synergize microfluidic techniques with advanced molecular biology methods, including reverse transcription polymerase chain reaction (RT-PCR), loop-mediated isothermal amplification (LAMP), and clustered regularly interspaced short palindromic repeats (CRISPR), have been successfully used to identify a diverse array of pathogens, including COVID-19, Ebola, Zika, and dengue fever. This review outlines the advances in pathogen detection, attributing them to the integration of microfluidic technology with traditional molecular biology methods and smartphone- and paper-based diagnostic assays. The cutting-edge diagnostic technologies are of critical importance for disease prevention and epidemic surveillance. Looking ahead, research is expected to focus on increasing detection sensitivity, streamlining testing processes, reducing costs, and enhancing the capability for remote data sharing. These improvements aim to achieve broader coverage and quicker response mechanisms, thereby constructing a more robust defense for global public health security.

Keywords